Sunday, May 22, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | For Likes Of India Pfizer Is On Vax Version Requiring Simple Refrigeration

For likes of India, Pfizer is on vax version requiring simple refrigeration

By IANS
Published: Updated On - 05:44 PM, Wed - 9 December 20
Pfizer's mRNA technology-based vaccine has an efficacy of over 90 per cent with a double dose and 67 per cent with a single dose. It, however, requires minus 70 degrees Celsius, which does not match India's cold storage facilities.

New Delhi: US Drugmaker Pfizer, which had recently sought emergency use authorization of its coronavirus vaccine in India and whose shot require storage at minus 70 degrees Celsius, has revealed that the company is working on a new formulation which will be able to avoid storage at extreme temperature and can be stored in simple refrigeration.

Pfizer’s mRNA technology-based vaccine has an efficacy of over 90 per cent with a double dose and 67 per cent with a single dose. It, however, requires minus 70 degrees Celsius, which does not match India’s cold storage facilities.

Clarifying on the issue, Albert Bourla, Pfizer’s Chief Executive Officer (CEO), said at a press conference organized by the International Federation of Pharmaceutical Manufacturers and Associations: “We are working on a new formulation that will be able to avoid minus 70-degree Celsius temperature and can be stored in simple refrigeration.”

Bourla made the comment when asked, “Are you working on versions of your vaccine that can be stored in less extreme temperature in countries like India?”

He, however, emphasized that the company is currently confident about their ability to distribute the product at minus 70-degree Celsius. Besides this, Bourla charted out a detailed logistical plan and tools to support vaccine storage, temperature monitoring, and transport.

The multinational biopharmaceutical company had sought approval for emergency use authorization of its vaccine candidate in India on December 6 after getting clearance in the UK and Bahrain.

A Subject Expert Committee will take decision in the coming weeks.

To allay the fear of public on the safety of the vaccine, the Chief Executive Officer said: “In this case, the vaccines were developed very fast. What I will tell them that we did not cut corners. We tested this vaccine with the exact same way that we are testing any vaccine. Because of the scrutiny, it was tested with even higher standards.”

On Tuesday, the Union Health Ministry informed that as many as eight Covid-19 vaccine candidates are under different stages of clinical trials which could be ready for authorization in near future. Besides Pfizer, Bharat Biotech and Serum Institute of India have recently sought emergency use authorization of their vaccine.

  • Follow Us :
  • Tags
  • Corona Virus Deaths
  • Coronavirus
  • Coronavirus in India
  • Coronavirus Latest Updates

Related News

  • Hyderabad’s Malkam Cheruvu turns idyllic spot

  • Hyderabad: Swanky skywalk to ease pedestrian woes at Mehdipatnam

  • Telangana Green Fund yielding results, over Rs 64.80 lakh collected so far

  • Bandi Sanjay flays Telangana govt for not reducing VAT on petroleum products

  • Hyderabad: Woman kills step son at Kachiguda

  • PM Modi lauds Thomas Cup team

Latest News

  • Opinion: Renewables cannot replace coal

    13 mins ago
  • Game On: A return to the basics

    28 mins ago
  • Editorial: Unequal Republic

    43 mins ago
  • AC Milan secure 1st Serie A title in 11 years

    1 hour ago
  • Current Affairs: Who did what and when?

    1 hour ago
  • IPL 2022: PBKS register 5-wicket win over SRH, finish tournament on a high

    1 hour ago
  • Hyderabad: ‘Okati coffee’ will soothe your soul

    1 hour ago
  • Know the Science behind detecting antibodies

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam